Thursday, June 21, 2018
 
 
Company News: Page (1) of 1 - 05/01/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention of Recurrent VVC
QIDP provides five additional years of market exclusivity, and Fast Track expedites the regulatory pathEnrollment completed in Phase 2b DOVE study in VVC; on-track for top-line data by July 2018Initia...
(May 01, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Medicine,Disease,healthcare,Pregnancy,Surgery,Medication,Pregnancy,Lifestyle,Other,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines